pudafensine   Click here for help

GtoPdb Ligand ID: 13226

Synonyms: IP2015 | IPED-2015 | IPED2015
Compound class: Synthetic organic
Comment: The chemical structure for pudafensine was obtained from proposed INN list 130 (Feb. 2024), in which the compound is described as a monoamine reuptake inhibitor. Online information indicates that this is Initiator Pharma's clinical candidate IP2015.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 3
Topological polar surface area 56.79
Molecular weight 303.35
XLogP 1.29
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COC1CC2=CC=C(C=C2OC1=O)O[C@H]3C[C@]4([H])CC[C@]([H])(C3)N4
Isomeric SMILES [H][C@]12CC[C@]([H])(C[C@H](C1)OC3=CC4=C(CC(OC)C(=O)O4)C=C3)N2
InChI InChI=1S/C17H21NO4/c1-20-16-6-10-2-5-13(9-15(10)22-17(16)19)21-14-7-11-3-4-12(8-14)18-11/h2,5,9,11-12,14,16,18H,3-4,6-8H2,1H3/t11-,12+,14-,16?
InChI Key WPAFIYCKXZOAAG-ABOKDIFFSA-N
No information available.
Summary of Clinical Use Click here for help
Pudafensine (IP2015) has been advanced as a clinical candidate for organic erectile dysfunction and neuropathic pain.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT05728671 Bioavailability Study to Compare Liquid vs Two Solid Formulations of IP2015 Phase 1 Interventional Initiator Pharma
NCT05181852 Study to Investigate the Pharmacodynamic Effects of IP2015 in Healthy Male Subjects Using the Intradermal Capsaicin Model Phase 1 Interventional Initiator Pharma
NCT04969666 A Phase II, Repeat Single Oral Dose Study of IPED2015 in Healthy Male Subjects With Erectile Dysfunction Phase 2 Interventional Initiator Pharma